Search alternatives:
cell » well (Expand Search)
Showing 1 - 20 results of 51 for search 'Natural killer cell engagers', query time: 0.19s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors by Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson, Patrick A. Baeuerle

    Published 2023-12-01
    “…In particular, the engagement of natural killer (NK) cells as potent effectors of the innate immune response has emerged as a promising modality in immunotherapy. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9

    Mechanisms of Innate Lymphoid Cell and Natural Killer T Cell Activation during Mucosal Inflammation by David Nau, Nora Altmayer, Jochen Mattner

    Published 2014-01-01
    “…Due to their abundance at mucosal tissue sites and their powerful immunomodulatory capacities, the role of innate lymphoid cells (ILCs) and natural killer T (NKT) cells in the maintenance of mucosal tolerance has recently moved into the focus of attention. …”
    Get full text
    Article
  10. 10

    Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment by Hyukmin In, Minkyoung Park, Hyeonsik Lee, Kyung Ho Han

    Published 2025-02-01
    “…By engaging T cells, natural killer (NK) cells, and phagocytes, ICEs overcome challenges such as immune evasion and MHC downregulation, addressing critical barriers in cancer treatment. …”
    Get full text
    Article
  11. 11

    Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Leishmania Infection by Ana Valério-Bolas, Mafalda Meunier, Armanda Rodrigues, Joana Palma-Marques, Rui Ferreira, Inês Cardoso, Lis Lobo, Marta Monteiro, Telmo Nunes, Ana Armada, Wilson T. Antunes, Graça Alexandre-Pires, Isabel Pereira da Fonseca, Gabriela Santos-Gomes

    Published 2025-01-01
    “…The innate immune response is the first defense line against pathogens, which includes natural killer (NK) and dendritic cells (DCs). By recognizing and ultimately destroying infected cells, and by secreting immune mediators that favor inflammatory microenvironments, NK cells take the lead in the infectious process. …”
    Get full text
    Article
  12. 12
  13. 13

    CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma by Lei Shi, Christian M Capitini, Amy K Erbe, Fernanda Szewc, Longzhen Song, Matthew H Forsberg, David P Turicek, Paul D Bates, Devin M Burpee, Aicha E Quamine, Johnathan D Ebben, Jillian M Kline, Emily O Lafeber, Madison F Phillips, Monica M Cho, Amanda S Ceas, John A Kink

    Published 2025-04-01
    “…OS expresses CD155 which interacts strongly with inhibitory receptors TIGIT and CD96 but also binds to activating receptor DNAM-1 on natural killer (NK) cells. CD155 has never been targeted after alloBMT. …”
    Get full text
    Article
  14. 14
  15. 15

    Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands by Daniel Fallon, Ching-Shin Huang, Jingya Ma, Christopher Morgan, Zhaohui Sunny Zhou

    Published 2024-12-01
    “…Natural killer (NK) cells are effector cells of the innate immune system that distinguish between healthy and abnormal cells through activating and inhibitory receptor signaling. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18

    4‐1BB and cytokines trigger human NK, γδ T, and CD8+ T cell proliferation and activation, but are not required for their effector functions by Laurent Vidard

    Published 2023-01-01
    “…Abstract Introduction This study was designed to compare the costimulatory molecules and cytokines required to trigger the proliferation and activation of natural killer (NK), γδ T, and CD8+ T cells, and gain in‐depth insight into the mechanisms shifting tolerance to immunity. …”
    Get full text
    Article
  19. 19
  20. 20

    Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice by Ge Yang, Mohammad Massumi, Shahryar Khoshtinat Nikkhoi, Hajar Owji, Mayara Grizotte-Lake, Rick I Cohen, Lazaro Gil Gonzalez, Arash Hatefi

    Published 2024-03-01
    “…Background In a prior report, we detailed the isolation and engineering of a bispecific killer cell engager, referred to as BiKE:E5C1. The BiKE:E5C1 exhibits high affinity/specificity for the CD16a activating receptor on natural killer (NK) cells and human epidermal growth factor receptor 2 (HER2) on cancer cells. …”
    Get full text
    Article